A detailed history of Aton Ra Partners transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Aton Ra Partners holds 10,435 shares of BCYC stock, worth $153,290. This represents 0.38% of its overall portfolio holdings.

Number of Shares
10,435
Previous 11,588 9.95%
Holding current value
$153,290
Previous $232,000 18.97%
% of portfolio
0.38%
Previous 0.49%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$13.29 - $22.2 $15,323 - $25,596
-1,153 Reduced 9.95%
10,435 $188,000
Q3 2023

Oct 25, 2023

SELL
$19.9 - $26.25 $52,356 - $69,063
-2,631 Reduced 18.5%
11,588 $232,000
Q2 2023

Jul 18, 2023

SELL
$18.95 - $28.67 $18,002 - $27,236
-950 Reduced 6.26%
14,219 $362,000
Q1 2023

May 05, 2023

SELL
$20.02 - $31.37 $37,997 - $59,540
-1,898 Reduced 11.12%
15,169 $322,000
Q4 2022

Feb 02, 2023

SELL
$20.37 - $32.9 $92,214 - $148,938
-4,527 Reduced 20.96%
17,067 $505,000
Q3 2022

Nov 14, 2022

SELL
$17.49 - $28.44 $24,923 - $40,527
-1,425 Reduced 6.19%
21,594 $502,000
Q2 2022

Aug 15, 2022

BUY
$12.95 - $46.99 $82,802 - $300,454
6,394 Added 38.46%
23,019 $386,000
Q1 2022

May 16, 2022

BUY
$40.12 - $59.5 $666,995 - $989,187
16,625 New
16,625 $730,000

Others Institutions Holding BCYC

About BICYCLE THERAPEUTICS plc


  • Ticker BCYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,676,100
  • Market Cap $436M
  • Description
  • Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...
More about BCYC
Track This Portfolio

Track Aton Ra Partners Portfolio

Follow Aton Ra Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

News

Stay updated on Aton Ra Partners with notifications on news.